AbbVie opens up to bigger deals as competition heats up — report; Small radiopharmaceutical player goes public via reverse merger

AbbVie is looking to make a push this year on new drugs — and it’s ready to spend for it.

According to a report from the Wall Street Journal, AbbVie is keen to replace the potential sales that could be lost from Humira and will be…